Showing results (261-270 of 352) with videos related to
Sort By:
Pageof 36
Journal of Drugs in Dermatology : JDD|September 4, 2024
Advances in Technology for Melanoma Diagnosis and Prognosis: An Expert Consensus PanelJoshua Burshtein, Danny Zakria, Milaan Shah, et al.Pharmacoeconomics|August 12, 2003
Validation of expert opinion in identifying comorbidities associated with atopic dermatitis/eczemaCharles N Ellis, Lynn A Drake, Mary M Prendergast, et al.The Journal of Allergy and Clinical Immunology. in Practice|October 4, 2017
Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging TherapiesMark Boguniewicz, Andrew F Alexis, Lisa A Beck, et al.International Journal of Dermatology|November 1, 2015
Psychometric validation of the Psoriasis Symptom Diary using Phase III study data from patients with chronic plaque psoriasisBruce Strober, Yang Zhao, Mary Helen Tran, et al.Journal of Drugs in Dermatology : JDD|February 23, 2019
Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in PracticeMark Lebwohl, Andrew F. Alexis, Lisa A. Beck, et al.Journal of Psoriasis and Psoriatic Arthritis|December 1, 2025
Patient Experiences on the Diagnosis, Management, and Burden of Generalized Pustular Psoriasis: An International Web Survey and Qualitative Interview StudyMark Lebwohl, Hideki Fujita, Kilian Eyerich, et al.Dermatology Online Journal|October 31, 2025
How Janus kinase selectivity impacts efficacy and safety of abrocitinib for atopic dermatitis: an expert consensus panelAngela Rosenberg, Danny Zakria, Lauren DeBusk, et al.RMD Open|March 10, 2026
Bimekizumab longer-term safety profile in adult patients with axial spondyloarthritis or psoriatic arthritis: an updated analysis of six phase IIb/III clinical studiesPhilip J Mease, Joseph F Merola, Marina Magrey, et al.Dermatology and Therapy|May 14, 2026
Summary of Research: Apremilast Improves Skin Outcomes in Pediatric Plaque Psoriasis of Shorter Disease Duration: 52-Week Results from the SPROUT Phase 3 TrialRichard G Langley, Lisa Arkin, Loretta Fiorillo, et al.Journal of Drugs in Dermatology : JDD|August 16, 2021
Serious Gastrointestinal-Related Adverse Events Among Psoriasis Patients Treated With Guselkumab in VOYAGE 1 and VOYAGE 2Peter Foley, Kristian Reich, Andrew Blauvelt, et al.Pageof 36